首页 > 最新文献

Cardiovascular & hematological disorders drug targets最新文献

英文 中文
Acute Myeloid Leukemia Presenting as Extensive Arterial and Venous Thrombosis: A Case Report. 急性髓性白血病表现为广泛的动脉和静脉血栓:病例报告。
Pub Date : 2024-10-30 DOI: 10.2174/011871529X334859241016114027
Arjun Kachhwaha, Bibhant Shah, Kavya Ronanki, Prisla Maria Dalton, Uttam Kumar Nath

Background: Thromboembolism with solid malignancies is a commonly associated feature, which is less common in hematological malignancies. Disseminated intravascular coagulation (DIC) causing thrombotic events is characteristically associated with certain hematological malignancies (e.g., acute promyelocytic leukemia (APL). Acute myeloid leukemia (AML) presenting as extensive thromboembolism is not a common clinical presentation. Anticoagulation in these subsets of patients remains a major challenge since patients often have thrombocytopenia and bleeding manifestations, requiring close monitoring.

Case presentation: A 54-year-old male with a known case of ischemic heart disease on regular anti- platelet therapy presented with acute onset progressive shortness of breath with mild anemia. On further evaluation, the patient was diagnosed with bilateral pulmonary artery and venous thrombosis along with left complete renal and partial inferior vena cava (IVC) thrombosis. The patient was started safely on anticoagulant therapy with normal platelet counts. Later, peripheral smear and immunophenotyping by flow cytometry revealed the diagnosis of acute myeloid leukemia, and the patient started its treatment.

Conclusion: Extensive arterial and venous thrombosis at presentation of acute myeloid leukemia is an uncommon finding and needs anticoagulation therapy along with the treatment of the underlying disease. Close monitoring of bleeding and maintaining an adequate platelet count is required, especially in hematological malignancies.

背景:血栓栓塞是实体恶性肿瘤的常见特征,但在血液恶性肿瘤中并不常见。导致血栓事件的弥散性血管内凝血(DIC)是某些血液恶性肿瘤(如急性早幼粒细胞白血病(APL))的典型特征。急性髓性白血病(AML)出现广泛血栓栓塞的临床表现并不常见。这些亚群患者的抗凝治疗仍是一大挑战,因为患者通常有血小板减少和出血表现,需要密切监测:一名 54 岁的男性患者,已知患有缺血性心脏病,正在接受常规抗血小板治疗,因急性发作进行性气短伴轻度贫血而就诊。经进一步评估,患者被诊断为双侧肺动脉和静脉血栓形成,同时伴有左肾和部分下腔静脉(IVC)血栓形成。患者开始安全地接受抗凝治疗,血小板计数正常。后来,外周涂片和流式细胞术免疫分型显示,患者被诊断为急性髓性白血病,并开始接受治疗:结论:急性髓性白血病发病时出现广泛的动静脉血栓形成并不常见,需要在治疗基础疾病的同时进行抗凝治疗。需要密切监测出血情况并保持足够的血小板数量,尤其是血液恶性肿瘤患者。
{"title":"Acute Myeloid Leukemia Presenting as Extensive Arterial and Venous Thrombosis: A Case Report.","authors":"Arjun Kachhwaha, Bibhant Shah, Kavya Ronanki, Prisla Maria Dalton, Uttam Kumar Nath","doi":"10.2174/011871529X334859241016114027","DOIUrl":"https://doi.org/10.2174/011871529X334859241016114027","url":null,"abstract":"<p><strong>Background: </strong>Thromboembolism with solid malignancies is a commonly associated feature, which is less common in hematological malignancies. Disseminated intravascular coagulation (DIC) causing thrombotic events is characteristically associated with certain hematological malignancies (e.g., acute promyelocytic leukemia (APL). Acute myeloid leukemia (AML) presenting as extensive thromboembolism is not a common clinical presentation. Anticoagulation in these subsets of patients remains a major challenge since patients often have thrombocytopenia and bleeding manifestations, requiring close monitoring.</p><p><strong>Case presentation: </strong>A 54-year-old male with a known case of ischemic heart disease on regular anti- platelet therapy presented with acute onset progressive shortness of breath with mild anemia. On further evaluation, the patient was diagnosed with bilateral pulmonary artery and venous thrombosis along with left complete renal and partial inferior vena cava (IVC) thrombosis. The patient was started safely on anticoagulant therapy with normal platelet counts. Later, peripheral smear and immunophenotyping by flow cytometry revealed the diagnosis of acute myeloid leukemia, and the patient started its treatment.</p><p><strong>Conclusion: </strong>Extensive arterial and venous thrombosis at presentation of acute myeloid leukemia is an uncommon finding and needs anticoagulation therapy along with the treatment of the underlying disease. Close monitoring of bleeding and maintaining an adequate platelet count is required, especially in hematological malignancies.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inter-atrial Septum Stenting in Congenital Heart Disease Patient: A Case Series in Indonesia. 先天性心脏病患者的房间隔支架植入术:印度尼西亚病例系列。
Pub Date : 2024-10-15 DOI: 10.2174/011871529X320825240925073605
Radityo Prakoso, Yovi Kurniawati, Sisca Natalia Siagian, Aditya Agita Sembiring, Damba Dwisepto Aulia Sakti, Brian Mendel, Olfi Lelya, Oktavia Lilyasari

Background: Inter-atrial septum (IAS) stenting in duct-dependent congenital heart disease patient has shown to be an effective way to maintain inter-atrial blood flow, however it is still considered a high risk procedure and inter-atrial septum stenting remains a low-frequency procedure.

Method: A single-center observational cohort study was carried out at the National Cardiovascular Center Harapan Kita (NCCHK) between April 2019 and April 2023. This study included duct-dependent congenital heart disease patients. The extracted data were baseline characteristics, clinical findings, complications, and outcomes of the patients.

Result: Eleven patients with duct-dependent physiology were intervened with inter-atrial septum stenting. The patients were 4 females and 7 males with the median age of implantation being 150 days (range 11-703 days) and the median weight being 3.9 (range 2.8-9) kg, with 2 patients weighing less than 3 kg. The average stent diameter was 8.50 (2.03) mm with an average length of 24.45 (7.94) mm. Non-restrictive atrial flow was successfully achieved in 90.90% of the procedures, corresponding to 10 patients.

Conclusion: Inter-atrial septum stenting in duct-dependent congenital heart disease patients produces reliable patency with a very good intra-procedural success rate.

背景:对导管依赖型先天性心脏病患者进行房间隔(IAS)支架植入术已被证明是维持房间隔血流的有效方法,但它仍被认为是一种高风险手术,房间隔支架植入术仍是一种低频手术:方法:2019 年 4 月至 2023 年 4 月期间,日本北海道国立心血管中心(NCCHK)开展了一项单中心观察性队列研究。研究对象包括导管依赖型先天性心脏病患者。提取的数据包括患者的基线特征、临床发现、并发症和预后:结果:11 名导管依赖型先天性心脏病患者接受了房间隔支架植入术。患者中有 4 名女性和 7 名男性,植入年龄中位数为 150 天(11-703 天不等),体重中位数为 3.9 公斤(2.8-9 公斤不等),其中 2 名患者体重不足 3 公斤。支架平均直径为 8.50 (2.03) 毫米,平均长度为 24.45 (7.94) 毫米。90.90%的手术成功实现了非限制性心房血流,共有10例患者:结论:在导管依赖型先天性心脏病患者中进行房间隔支架植入术可获得可靠的通畅,且术中成功率非常高。
{"title":"Inter-atrial Septum Stenting in Congenital Heart Disease Patient: A Case Series in Indonesia.","authors":"Radityo Prakoso, Yovi Kurniawati, Sisca Natalia Siagian, Aditya Agita Sembiring, Damba Dwisepto Aulia Sakti, Brian Mendel, Olfi Lelya, Oktavia Lilyasari","doi":"10.2174/011871529X320825240925073605","DOIUrl":"https://doi.org/10.2174/011871529X320825240925073605","url":null,"abstract":"<p><strong>Background: </strong>Inter-atrial septum (IAS) stenting in duct-dependent congenital heart disease patient has shown to be an effective way to maintain inter-atrial blood flow, however it is still considered a high risk procedure and inter-atrial septum stenting remains a low-frequency procedure.</p><p><strong>Method: </strong>A single-center observational cohort study was carried out at the National Cardiovascular Center Harapan Kita (NCCHK) between April 2019 and April 2023. This study included duct-dependent congenital heart disease patients. The extracted data were baseline characteristics, clinical findings, complications, and outcomes of the patients.</p><p><strong>Result: </strong>Eleven patients with duct-dependent physiology were intervened with inter-atrial septum stenting. The patients were 4 females and 7 males with the median age of implantation being 150 days (range 11-703 days) and the median weight being 3.9 (range 2.8-9) kg, with 2 patients weighing less than 3 kg. The average stent diameter was 8.50 (2.03) mm with an average length of 24.45 (7.94) mm. Non-restrictive atrial flow was successfully achieved in 90.90% of the procedures, corresponding to 10 patients.</p><p><strong>Conclusion: </strong>Inter-atrial septum stenting in duct-dependent congenital heart disease patients produces reliable patency with a very good intra-procedural success rate.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Role of Secondary Metabolites from Plants and Microbes as Modulators of Macrophage Differentiation. 探索植物和微生物次生代谢物作为巨噬细胞分化调节剂的作用
Pub Date : 2024-10-11 DOI: 10.2174/011871529X327064241003072202
Prakhar Sharma, Modi Kiran Piyushbhai, Kaliyamurthi Venkatachalam, Ambika Binesh

Recent research has uncovered that secondary metabolites-biologically active compounds produced by plants, microbes, and other organisms-play a significant role in regulating the differentiation and function of macrophages. Macrophages, key components of the innate immune system, are crucial for a wide range of physiological processes, including immune response modulation, tissue homeostasis, and host defense against pathogens. This research delves into the mechanisms by which secondary metabolites influence macrophage differentiation signaling pathways, with a focus on how specific compounds affect macrophage polarization and functional phenotypes. Understanding these effects can open new avenues for developing therapeutic strategies that target macrophage-mediated immune responses. Secondary metabolites, such as nitrogen (N) and sulfur (S) containing compounds, terpenoids, and phenolic compounds from plants and microbes, can modulate macrophage differentiation by influencing cytokine production and activity. The activation of signaling pathways in macrophages involves multiple receptors and transcription factors, including IFN-γ receptor activation leading to STAT1 activation, TLR4 triggering IRF5, NFκB, and AP1, IL-4 receptor activation leading to STAT6 and IRF4 activation, PPARγ activation via the fatty acid receptor, TLR4 increasing CREB and C/EBP levels. The complex interplay between transcription factors and cytokines is crucial for maintaining the balance between the M1 and M2 states of macrophages. Despite these insights, further research is needed to unravel the specific molecular mechanisms involved and to identify promising secondary metabolites that could be translated into clinical applications.

最近的研究发现,次生代谢物--由植物、微生物和其他生物产生的生物活性化合物--在调节巨噬细胞的分化和功能方面发挥着重要作用。巨噬细胞是先天性免疫系统的关键组成部分,对免疫反应调节、组织稳态和宿主抵御病原体等一系列生理过程至关重要。本研究深入探讨次生代谢物影响巨噬细胞分化信号通路的机制,重点研究特定化合物如何影响巨噬细胞的极化和功能表型。了解这些影响可为开发针对巨噬细胞介导的免疫反应的治疗策略开辟新途径。次生代谢物,如植物和微生物中的含氮(N)和含硫(S)化合物、萜类化合物和酚类化合物,可通过影响细胞因子的产生和活性来调节巨噬细胞的分化。巨噬细胞信号通路的激活涉及多种受体和转录因子,包括 IFN-γ 受体激活导致 STAT1 激活,TLR4 触发 IRF5、NFκB 和 AP1,IL-4 受体激活导致 STAT6 和 IRF4 激活,PPARγ 通过脂肪酸受体激活,TLR4 提高 CREB 和 C/EBP 水平。转录因子和细胞因子之间复杂的相互作用对于维持巨噬细胞 M1 和 M2 状态之间的平衡至关重要。尽管有了这些见解,但仍需进一步研究,以揭示其中涉及的具体分子机制,并确定有希望转化为临床应用的次生代谢物。
{"title":"Exploring the Role of Secondary Metabolites from Plants and Microbes as Modulators of Macrophage Differentiation.","authors":"Prakhar Sharma, Modi Kiran Piyushbhai, Kaliyamurthi Venkatachalam, Ambika Binesh","doi":"10.2174/011871529X327064241003072202","DOIUrl":"https://doi.org/10.2174/011871529X327064241003072202","url":null,"abstract":"<p><p>Recent research has uncovered that secondary metabolites-biologically active compounds produced by plants, microbes, and other organisms-play a significant role in regulating the differentiation and function of macrophages. Macrophages, key components of the innate immune system, are crucial for a wide range of physiological processes, including immune response modulation, tissue homeostasis, and host defense against pathogens. This research delves into the mechanisms by which secondary metabolites influence macrophage differentiation signaling pathways, with a focus on how specific compounds affect macrophage polarization and functional phenotypes. Understanding these effects can open new avenues for developing therapeutic strategies that target macrophage-mediated immune responses. Secondary metabolites, such as nitrogen (N) and sulfur (S) containing compounds, terpenoids, and phenolic compounds from plants and microbes, can modulate macrophage differentiation by influencing cytokine production and activity. The activation of signaling pathways in macrophages involves multiple receptors and transcription factors, including IFN-γ receptor activation leading to STAT1 activation, TLR4 triggering IRF5, NFκB, and AP1, IL-4 receptor activation leading to STAT6 and IRF4 activation, PPARγ activation via the fatty acid receptor, TLR4 increasing CREB and C/EBP levels. The complex interplay between transcription factors and cytokines is crucial for maintaining the balance between the M1 and M2 states of macrophages. Despite these insights, further research is needed to unravel the specific molecular mechanisms involved and to identify promising secondary metabolites that could be translated into clinical applications.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dengue Fever Related Reactive Thrombocytosis in Young Male: A Case Report and Review Literature. 年轻男性登革热相关反应性血小板增多症:病例报告与文献综述
Pub Date : 2024-09-25 DOI: 10.2174/011871529X325967240916075554
Jitendra Singh, Anju Dinkar, Nilesh Kumar, Kailash Kumar, Vikrant

Introduction: Dengue fever is prevalent in tropical nations, especially India. Leucopenia and thrombocytopenia are distinctive features of acute dengue fever that revert to normal levels after the patient's recovery. Dengue fever is associated with numerous unusual clinical manifestations of different body systems. Additionally, the emergence of severe thrombocytosis following thrombocytopenia is extremely rare. Based on our extensive knowledge, only three cases similar to this have been documented in the literature.

Case report: Here, we present a case of a 36-year-old healthy man who had acute dengue and subsequently developed severe reactive thrombocytosis. The patient was treated conservatively and discharged. Subsequently, he developed thrombocytosis. Aspirin was given for a short period to alleviate any potential repercussions.

Conclusion: Thrombocytosis, a rare consequence of dengue infection, is usually asymptomatic. Nevertheless, ongoing monitoring of dengue patients is required to avoid complications.

简介登革热流行于热带国家,尤其是印度。白细胞减少症和血小板减少症是急性登革热的显著特征,在病人康复后可恢复到正常水平。登革热与不同身体系统的许多异常临床表现有关。此外,在血小板减少后出现严重的血小板增多症也极为罕见。根据我们广泛的知识,文献中仅记载了三例类似病例:在此,我们介绍了一例 36 岁的健康男性病例,他曾患急性登革热,随后出现了严重的反应性血小板增多症。患者接受保守治疗后出院。随后,他又出现了血小板增多。为减轻任何潜在的影响,患者短期服用了阿司匹林:血小板增多是登革热感染的一种罕见后果,通常没有症状。尽管如此,仍需对登革热患者进行持续监测,以避免并发症的发生。
{"title":"Dengue Fever Related Reactive Thrombocytosis in Young Male: A Case Report and Review Literature.","authors":"Jitendra Singh, Anju Dinkar, Nilesh Kumar, Kailash Kumar, Vikrant","doi":"10.2174/011871529X325967240916075554","DOIUrl":"https://doi.org/10.2174/011871529X325967240916075554","url":null,"abstract":"<p><strong>Introduction: </strong>Dengue fever is prevalent in tropical nations, especially India. Leucopenia and thrombocytopenia are distinctive features of acute dengue fever that revert to normal levels after the patient's recovery. Dengue fever is associated with numerous unusual clinical manifestations of different body systems. Additionally, the emergence of severe thrombocytosis following thrombocytopenia is extremely rare. Based on our extensive knowledge, only three cases similar to this have been documented in the literature.</p><p><strong>Case report: </strong>Here, we present a case of a 36-year-old healthy man who had acute dengue and subsequently developed severe reactive thrombocytosis. The patient was treated conservatively and discharged. Subsequently, he developed thrombocytosis. Aspirin was given for a short period to alleviate any potential repercussions.</p><p><strong>Conclusion: </strong>Thrombocytosis, a rare consequence of dengue infection, is usually asymptomatic. Nevertheless, ongoing monitoring of dengue patients is required to avoid complications.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toll-like Receptors: Therapeutic Potential in Life Threatening Diseases-Cardiac Disorders. Toll 样受体:威胁生命的疾病--心脏疾病的治疗潜力。
Pub Date : 2024-09-24 DOI: 10.2174/011871529X348433240915133309
Sonia Singh

Toll-like receptors (TLRs) belong to the innate immune system. TLRs identify and respond to invading pathogens by recognizing certain molecular patterns associated with the infections. TLRs are crucial for the host's defence against these diseases. TLRs are capable of detecting several endogenous chemicals through the recognition of damage-associated molecular patterns, which are generated in response to various harmful situations. Recent animal studies have shown that TLR signaling has a significant role in the development of serious heart diseases, such as ischemia myocardial damage, myocarditis, and septic cardiomyopathy, where inflammation of the heart muscle is a key factor. This manuscript examines the animal research findings on (1) TLRs, TLR ligands, and the signal transduction system, and (2) the significant involvement of TLR signaling in these crucial cardiac diseases.

Toll 样受体(TLR)属于先天性免疫系统。TLRs 通过识别与感染有关的某些分子模式来识别入侵的病原体并做出反应。TLR 对于宿主抵御这些疾病至关重要。TLRs 能够通过识别在各种有害情况下产生的损伤相关分子模式来检测几种内源性化学物质。最近的动物研究表明,TLR 信号在缺血性心肌损伤、心肌炎和脓毒性心肌病等严重心脏疾病的发病过程中起着重要作用,而心肌发炎是其中的一个关键因素。本手稿探讨了有关以下方面的动物研究成果:(1) TLR、TLR 配体和信号转导系统;(2) TLR 信号在这些重要心脏疾病中的重要作用。
{"title":"Toll-like Receptors: Therapeutic Potential in Life Threatening Diseases-Cardiac Disorders.","authors":"Sonia Singh","doi":"10.2174/011871529X348433240915133309","DOIUrl":"https://doi.org/10.2174/011871529X348433240915133309","url":null,"abstract":"<p><p>Toll-like receptors (TLRs) belong to the innate immune system. TLRs identify and respond to invading pathogens by recognizing certain molecular patterns associated with the infections. TLRs are crucial for the host's defence against these diseases. TLRs are capable of detecting several endogenous chemicals through the recognition of damage-associated molecular patterns, which are generated in response to various harmful situations. Recent animal studies have shown that TLR signaling has a significant role in the development of serious heart diseases, such as ischemia myocardial damage, myocarditis, and septic cardiomyopathy, where inflammation of the heart muscle is a key factor. This manuscript examines the animal research findings on (1) TLRs, TLR ligands, and the signal transduction system, and (2) the significant involvement of TLR signaling in these crucial cardiac diseases.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Interactions between a Potential Antimalarial 'MAL2-11B' and its Targets using In Silico Methods. 利用硅学方法了解潜在抗疟药物 "MAL2-11B "与其靶标之间的相互作用
Pub Date : 2024-08-23 DOI: 10.2174/011871529X309936240821072630
Komalpreet Kaur Sandhu, Satinder Kaur, Rachna Hora, Prakash Chandra Mishra

Introduction: The 70 kDa heat shock proteins (Hsp70) are ubiquitous molecules that play central roles in protein homeostasis. Their nucleotide-binding domains (NBD) are associated with the J domains of 40 kDa co-chaperone 'HSP40' in performing their functions. Interruption of this interaction significantly impacts the critical ATPase activity of Hsp70s, making them dysfunctional.

Methods: MAL2-11B is a dihydropyrimidine derivative that blocks Hsp70-Hsp40 interaction and hence holds the potential to be used as a drug. This Hsp70 inhibitor is a structural analogue of MAL3-101 that has proven anti-cancer and antiparasitic activity. MAL2-11B is predicted to have better drug-likeness, solubility, and absorption properties than MAL3-101. In the present study, we have therefore explored the potential of MAL2-11B as an antimalarial by using in silico tools.

Results: Molecular docking of MAL2-11B with all Plasmodium falciparum Hsp70 (PfHsp70) proteins revealed its preferential affinity for two out of four homologs at the nucleotide-binding site. Detailed analysis of the docked complexes helped us to predict the kind of protein-inhibitor interactions and specific amino acid residues involved in binding.

Conclusion: After in vitro validation, these data may be used as the groundwork for the design and development of new inhibitors and drugs against malaria.

引言70 kDa 热休克蛋白(Hsp70)是一种无处不在的分子,在蛋白质平衡中发挥着核心作用。它们的核苷酸结合结构域(NBD)与 40 kDa 协同伴侣 "HSP40 "的 J 结构域相关联,共同发挥其功能。这种相互作用的中断会严重影响 Hsp70s 的关键 ATPase 活性,使其功能失调:MAL2-11B是一种二氢嘧啶衍生物,它能阻断Hsp70与Hsp40的相互作用,因此有可能被用作药物。这种 Hsp70 抑制剂是 MAL3-101 的结构类似物,后者已被证实具有抗癌和抗寄生虫活性。据预测,MAL2-11B 比 MAL3-101 具有更好的药物相似性、可溶性和吸收特性。因此,在本研究中,我们利用硅学工具探索了 MAL2-11B 作为抗疟药物的潜力:结果:MAL2-11B与所有恶性疟原虫Hsp70(PfHsp70)蛋白的分子对接显示,在核苷酸结合位点上,MAL2-11B对四个同源蛋白中的两个具有优先亲和力。对对接复合物的详细分析帮助我们预测了蛋白质与抑制剂的相互作用类型以及参与结合的特定氨基酸残基:经过体外验证后,这些数据可作为设计和开发新的抑制剂和抗疟疾药物的基础。
{"title":"Understanding Interactions between a Potential Antimalarial 'MAL2-11B' and its Targets using In Silico Methods.","authors":"Komalpreet Kaur Sandhu, Satinder Kaur, Rachna Hora, Prakash Chandra Mishra","doi":"10.2174/011871529X309936240821072630","DOIUrl":"https://doi.org/10.2174/011871529X309936240821072630","url":null,"abstract":"<p><strong>Introduction: </strong>The 70 kDa heat shock proteins (Hsp70) are ubiquitous molecules that play central roles in protein homeostasis. Their nucleotide-binding domains (NBD) are associated with the J domains of 40 kDa co-chaperone 'HSP40' in performing their functions. Interruption of this interaction significantly impacts the critical ATPase activity of Hsp70s, making them dysfunctional.</p><p><strong>Methods: </strong>MAL2-11B is a dihydropyrimidine derivative that blocks Hsp70-Hsp40 interaction and hence holds the potential to be used as a drug. This Hsp70 inhibitor is a structural analogue of MAL3-101 that has proven anti-cancer and antiparasitic activity. MAL2-11B is predicted to have better drug-likeness, solubility, and absorption properties than MAL3-101. In the present study, we have therefore explored the potential of MAL2-11B as an antimalarial by using in silico tools.</p><p><strong>Results: </strong>Molecular docking of MAL2-11B with all Plasmodium falciparum Hsp70 (PfHsp70) proteins revealed its preferential affinity for two out of four homologs at the nucleotide-binding site. Detailed analysis of the docked complexes helped us to predict the kind of protein-inhibitor interactions and specific amino acid residues involved in binding.</p><p><strong>Conclusion: </strong>After in vitro validation, these data may be used as the groundwork for the design and development of new inhibitors and drugs against malaria.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Misdiagnosed Isolated Ruptured Mycotic Mitral Valve Aneurysm as Mitral Annulus Calcification. 被误诊为二尖瓣瓣环钙化的孤立性霉菌性二尖瓣破裂动脉瘤
Pub Date : 2024-07-26 DOI: 10.2174/011871529X313367240722040919
Sara Afshar, Mohsen Moohebati, Mehdi Kahrom, Kianmehr Rastgou, Mehrdad Hashemi, Vafa Baradaran Rahimi

Introduction: Subacute Bacterial Endocarditis (SBE) is a slowly developing type of infective endocarditis. Aneurysm is more common in this type of endocarditis. Currently, SBE is an uncommon cause of unexplained fever (FUO) because rapid diagnostic capabilities, such as echocardiography, have improved. Despite echocardiography, endocarditis and valvular aneurysm were missed in our patient due to the location and special shape of the aneurysm near the annulus.

Case representation: We present a case of SBE resulting in an isolated ruptured mycotic mitral valve aneurysm in a patient on dialysis. Mycotic mitral valve aneurysm is an uncommon and serious complication of infective endocarditis, particularly subacute endocarditis.

Conclusion: In order to diagnose this complication, there should be clinical suspicion in the presence of severe regurgitation without any cause, and a detailed echocardiography should be performed.

简介亚急性细菌性心内膜炎(SBE)是一种发展缓慢的感染性心内膜炎。动脉瘤在这种类型的心内膜炎中更为常见。目前,由于超声心动图等快速诊断能力的提高,SBE 已成为不明原因发热(FUO)的罕见病因。尽管进行了超声心动图检查,但由于瓣环附近动脉瘤的位置和特殊形状,我们的患者还是漏诊了心内膜炎和瓣膜动脉瘤:我们介绍了一例在透析患者中因孤立的霉菌性二尖瓣动脉瘤破裂而导致 SBE 的病例。霉菌性二尖瓣动脉瘤是感染性心内膜炎,尤其是亚急性心内膜炎的一种不常见的严重并发症:结论:为了诊断这种并发症,临床上应怀疑无任何原因的严重瓣膜反流,并进行详细的超声心动图检查。
{"title":"Misdiagnosed Isolated Ruptured Mycotic Mitral Valve Aneurysm as Mitral Annulus Calcification.","authors":"Sara Afshar, Mohsen Moohebati, Mehdi Kahrom, Kianmehr Rastgou, Mehrdad Hashemi, Vafa Baradaran Rahimi","doi":"10.2174/011871529X313367240722040919","DOIUrl":"https://doi.org/10.2174/011871529X313367240722040919","url":null,"abstract":"<p><strong>Introduction: </strong>Subacute Bacterial Endocarditis (SBE) is a slowly developing type of infective endocarditis. Aneurysm is more common in this type of endocarditis. Currently, SBE is an uncommon cause of unexplained fever (FUO) because rapid diagnostic capabilities, such as echocardiography, have improved. Despite echocardiography, endocarditis and valvular aneurysm were missed in our patient due to the location and special shape of the aneurysm near the annulus.</p><p><strong>Case representation: </strong>We present a case of SBE resulting in an isolated ruptured mycotic mitral valve aneurysm in a patient on dialysis. Mycotic mitral valve aneurysm is an uncommon and serious complication of infective endocarditis, particularly subacute endocarditis.</p><p><strong>Conclusion: </strong>In order to diagnose this complication, there should be clinical suspicion in the presence of severe regurgitation without any cause, and a detailed echocardiography should be performed.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Antihypertensive Potential of Aqueous extract of Peristrophe Bivalvis (L.) Merr. is via Up-regulation of Cyclic Guanosine Monophosphate and Down-regulation of the Renin-angiotensin System. Peristrophe Bivalvis (L.) Merr.水提取物通过上调单磷酸环鸟苷和下调肾素-血管紧张素系统发挥抗高血压作用
Pub Date : 2024-07-19 DOI: 10.2174/011871529X301799240715091918
Esther Oluwasola Aluko, Ubong Edem David, Abodunrin Adebayo Ojetola, Adesoji Adedipe Fasanmade

Background: Hypertension is a major risk factor for cardiovascular diseases. Peristrophe bivalvis (PB) is used for the treatment of hypertension, painful sprains, skin diseases, tuberculosis, acute bronchitis, anti-inflammatory conditions, hepatitis, and diabetes. Its antihypertensive potential has been investigated and documented. This study investigated the antihypertensive mechanism of aqueous extract of PB leaf (APB) on L-NAME-induced hypertension.

Methods: Thirty male wistar rats (150-170 g) were grouped into five (n=5). Group 1 received 10 mL/kg of distilled water (control), while groups 2-5 were administered 60 mg/kg of L-NAME (L-- NAME60) orally for eight weeks to induce hypertension. After eight weeks, groups 2-5 received L-NAME60+distilled water (HNT), distilled water (HRE), L-NAME60+APB (200 mg/kg, [HAPB]), and L-NAME60+ramipril (10 mg/kg, [HRA]), respectively, for five weeks. The BP was measured by the tail-cuff method. The blood sample was obtained under anesthesia, and tissue samples were obtained after euthanasia. Serum renin, ACE, angiotensin-II, endothelin-1, and cyclic guanosine monophosphate (cGMP) levels were measured using ELISA techniques. Malondialdehyde, superoxide dismutase (SOD), and reduced glutathione (GSH) levels were measured by spectrophotometry. Data were analyzed using ANOVA at α0.05.

Results: The BP significantly decreased in HAPB compared to HNT. Renin, ACE, and angiotensin-II levels significantly decreased while cGMP levels increased in the HAPB group compared to HNT. Malondialdehyde levels significantly decreased, and SOD and GSH levels increased compared to HNT.

Conclusion: Peristrophe bivalvis aqueous leaf extract reduced blood pressure in hypertensive rats by modulating the cGMP signalling pathway and the renin-angiotensin system.

背景:高血压是心血管疾病的主要风险因素:高血压是心血管疾病的主要危险因素。双壳贝母(PB)可用于治疗高血压、扭伤疼痛、皮肤病、肺结核、急性支气管炎、消炎、肝炎和糖尿病。其抗高血压的潜力已得到研究和记录。本研究探讨了枸杞叶水提取物(APB)对 L-NAME 引起的高血压的降压机制:方法:30 只雄性 Wistar 大鼠(150-170 克)分为 5 组(n=5)。第1组接受10毫升/千克蒸馏水(对照组),第2-5组口服60毫克/千克L-NAME(L-- NAME60)诱导高血压八周。八周后,2-5组分别接受L-NAME60+蒸馏水(HNT)、蒸馏水(HRE)、L-NAME60+APB(200毫克/千克,[HAPB])和L-NAME60+雷米普利(10毫克/千克,[HRA])治疗五周。血压测量采用尾袖法。血液样本在麻醉状态下采集,组织样本在安乐死后采集。使用 ELISA 技术测量血清肾素、ACE、血管紧张素-II、内皮素-1 和环磷酸鸟苷(cGMP)的水平。丙二醛、超氧化物歧化酶(SOD)和还原型谷胱甘肽(GSH)水平采用分光光度法进行测量。数据采用方差分析,α0.05:结果:与 HNT 相比,HAPB 的血压明显下降。与 HNT 相比,HAPB 组的肾素、ACE 和血管紧张素 II 水平明显下降,而 cGMP 水平上升。与 HNT 相比,丙二醛水平明显下降,SOD 和 GSH 水平上升:结论:双壳贝叶水提取物通过调节 cGMP 信号通路和肾素-血管紧张素系统降低了高血压大鼠的血压。
{"title":"The Antihypertensive Potential of Aqueous extract of Peristrophe Bivalvis (L.) Merr. is via Up-regulation of Cyclic Guanosine Monophosphate and Down-regulation of the Renin-angiotensin System.","authors":"Esther Oluwasola Aluko, Ubong Edem David, Abodunrin Adebayo Ojetola, Adesoji Adedipe Fasanmade","doi":"10.2174/011871529X301799240715091918","DOIUrl":"https://doi.org/10.2174/011871529X301799240715091918","url":null,"abstract":"<p><strong>Background: </strong>Hypertension is a major risk factor for cardiovascular diseases. Peristrophe bivalvis (PB) is used for the treatment of hypertension, painful sprains, skin diseases, tuberculosis, acute bronchitis, anti-inflammatory conditions, hepatitis, and diabetes. Its antihypertensive potential has been investigated and documented. This study investigated the antihypertensive mechanism of aqueous extract of PB leaf (APB) on L-NAME-induced hypertension.</p><p><strong>Methods: </strong>Thirty male wistar rats (150-170 g) were grouped into five (n=5). Group 1 received 10 mL/kg of distilled water (control), while groups 2-5 were administered 60 mg/kg of L-NAME (L-- NAME60) orally for eight weeks to induce hypertension. After eight weeks, groups 2-5 received L-NAME60+distilled water (HNT), distilled water (HRE), L-NAME60+APB (200 mg/kg, [HAPB]), and L-NAME60+ramipril (10 mg/kg, [HRA]), respectively, for five weeks. The BP was measured by the tail-cuff method. The blood sample was obtained under anesthesia, and tissue samples were obtained after euthanasia. Serum renin, ACE, angiotensin-II, endothelin-1, and cyclic guanosine monophosphate (cGMP) levels were measured using ELISA techniques. Malondialdehyde, superoxide dismutase (SOD), and reduced glutathione (GSH) levels were measured by spectrophotometry. Data were analyzed using ANOVA at α0.05.</p><p><strong>Results: </strong>The BP significantly decreased in HAPB compared to HNT. Renin, ACE, and angiotensin-II levels significantly decreased while cGMP levels increased in the HAPB group compared to HNT. Malondialdehyde levels significantly decreased, and SOD and GSH levels increased compared to HNT.</p><p><strong>Conclusion: </strong>Peristrophe bivalvis aqueous leaf extract reduced blood pressure in hypertensive rats by modulating the cGMP signalling pathway and the renin-angiotensin system.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate Destiny of Bifurcation Lesions Treated with Biomatrix Alpha Stents. 使用 Biomatrix Alpha 支架治疗分叉病变的即时命运。
Pub Date : 2024-07-15 DOI: 10.2174/011871529X313209240708073302
Mahdi Zahedi, Mohammad Javad Najafi, Mina Sadeghi, Alireza Fatemi

Background: About 15% of coronary artery interventions are performed on coronary artery bifurcation. Managing these lesions presents a significant therapeutic obstacle in the context of coronary artery issues. Addressing both immediate and lasting side effects of these lesions demands ongoing monitoring and action. The introduction of drug-eluting stents has raised hopes for better outcomes in patients experiencing cardiovascular events.

Methods: In this study, we selected 51 patients (out of 850) who had received ≥1 cobalt-chromium, biodegradable polymer, Biolimus A9-eluting stent (CoCr-BP-BES) Biomatrix Alpha stent. Immediately after stenting, thrombolysis in myocardial infarction (TIMI) flow score in the coronary artery and its bypass branch, plaque shift, and lateral dissection immediately after angioplasty were evaluated.

Results: The mean age for patients was 65 (±10.35) years, where 49.02% of them were male and 45.1% had diabetes. No lateral dissection and death were reported in any of the patients. Also, the TIMI flow grade was 3 for the main branch in all patients. Plaque shifts were compared at different degrees of the TIMI flow coronary artery bypass graft. A statistical study revealed a noteworthy distinction between the groups. There was no discernible change when gender, diabetes, systolic and diastolic blood pressure with plaque changes were all controlled for.

Conclusion: We discovered that the Biomatrix Alpha stents' instant clinical results are admissible. Our findings confirm the clinical utility of the recently developed biolimus-eluting (BES) stent technology, which combines the BA-9 medication, a thin-strut CoCr stent platform, and a biodegradable polymer. This aligns with the existing body of research on the most recent generation of drug-eluting stents (DES).

背景:大约 15%的冠状动脉介入手术是在冠状动脉分叉处进行的。在冠状动脉问题上,处理这些病变是一个重大的治疗障碍。要解决这些病变带来的直接和持久的副作用,需要持续的监测和行动。药物洗脱支架的问世为心血管事件患者获得更好的治疗效果带来了希望:在这项研究中,我们从 850 例患者中选择了 51 例接受了≥1 个钴铬、生物可降解聚合物、Biolimus A9 洗脱支架(CoCr-BP-BES)Biomatrix Alpha 支架的患者。支架植入后,立即对冠状动脉及其旁路分支的心肌梗死溶栓(TIMI)血流评分、斑块移位和血管成形术后的侧向夹层进行评估:患者平均年龄为 65(±10.35)岁,其中 49.02% 为男性,45.1% 患有糖尿病。所有患者均无侧壁剥离和死亡报告。此外,所有患者主支的 TIMI 血流分级均为 3 级。对不同程度的 TIMI 流量冠状动脉旁路移植术的斑块移位进行了比较。统计研究显示,各组之间存在显著差异。在对性别、糖尿病、收缩压和舒张压以及斑块变化进行控制后,没有发现明显的变化:我们发现,Biomatrix Alpha 支架的即时临床效果是值得认可的。我们的研究结果证实了最近开发的生物洗脱(BES)支架技术的临床实用性,该技术结合了 BA-9 药物、薄支架钴铬合金支架平台和生物可降解聚合物。这与最新一代药物洗脱支架(DES)的现有研究成果相吻合。
{"title":"Immediate Destiny of Bifurcation Lesions Treated with Biomatrix Alpha Stents.","authors":"Mahdi Zahedi, Mohammad Javad Najafi, Mina Sadeghi, Alireza Fatemi","doi":"10.2174/011871529X313209240708073302","DOIUrl":"https://doi.org/10.2174/011871529X313209240708073302","url":null,"abstract":"<p><strong>Background: </strong>About 15% of coronary artery interventions are performed on coronary artery bifurcation. Managing these lesions presents a significant therapeutic obstacle in the context of coronary artery issues. Addressing both immediate and lasting side effects of these lesions demands ongoing monitoring and action. The introduction of drug-eluting stents has raised hopes for better outcomes in patients experiencing cardiovascular events.</p><p><strong>Methods: </strong>In this study, we selected 51 patients (out of 850) who had received ≥1 cobalt-chromium, biodegradable polymer, Biolimus A9-eluting stent (CoCr-BP-BES) Biomatrix Alpha stent. Immediately after stenting, thrombolysis in myocardial infarction (TIMI) flow score in the coronary artery and its bypass branch, plaque shift, and lateral dissection immediately after angioplasty were evaluated.</p><p><strong>Results: </strong>The mean age for patients was 65 (±10.35) years, where 49.02% of them were male and 45.1% had diabetes. No lateral dissection and death were reported in any of the patients. Also, the TIMI flow grade was 3 for the main branch in all patients. Plaque shifts were compared at different degrees of the TIMI flow coronary artery bypass graft. A statistical study revealed a noteworthy distinction between the groups. There was no discernible change when gender, diabetes, systolic and diastolic blood pressure with plaque changes were all controlled for.</p><p><strong>Conclusion: </strong>We discovered that the Biomatrix Alpha stents' instant clinical results are admissible. Our findings confirm the clinical utility of the recently developed biolimus-eluting (BES) stent technology, which combines the BA-9 medication, a thin-strut CoCr stent platform, and a biodegradable polymer. This aligns with the existing body of research on the most recent generation of drug-eluting stents (DES).</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hematological Indices and Genetic Variants of Premature Ovarian Insufficiency: Machine Learning Approaches. 早发性卵巢功能不全的血液学指标和遗传变异:机器学习方法。
Pub Date : 2024-01-01 DOI: 10.2174/011871529X297081240613075328
Mohammad Reza Mirinezhad, Malihe Aghasizadeh, Hamideh Ghazizadeh, Anahid Hemmatpur, Mohammad Reza Fazl Mashhadi, Hamed Khedmatgozar, Amir Kiyoumarsioskouei, Ali Ebrahimi Dabagh, Mohammad Amin Mohammadi, Arezoo Rastegarmoghadam Ebrahimian, Melika Malek, Sara Moazedi, Simin Rashidian, Gordon A Ferns, Tayebeh Hamzehloei, Alireza Pasdar, Majid Ghayour-Mobarhan

Background: Premature Ovarian Insufficiency (POI) is associated with infertility. Little is known about the potential circulating biomarkers that could be used to predict POI. We have investigated the possible association between white and red blood cells, platelet indices, and eight established single nucleotide polymorphisms (SNPs) associated with POI risk.

Methods: 117 women with premature menopause (PM) and 183 healthy women without a history of menopause before age 40 were recruited for this study. The tetra-primer amplification refractory mutation system-polymerase chain reaction (Tetra ARMS PCR) and allele-specific oligonucleotides- polymerase chain reaction (ASO-PCR) were carried out for genotyping for eight SNPs reported to be associated with POI. Decision tree analysis was applied to test the diagnostic value of hematological parameters to identify the risk of POI.

Results: Women with POI had lower neutrophil (NEUT) and white blood cell (WBC), whereas red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and mean cell hemoglobin (MCH) were higher. Platelet (PLT) count was also lower in affected women. Our data also indicated that HGB and HCT count were significantly associated with rs16991615 and rs244715. Mean Platelet volume (MPV) and platelet distribution width (PDW) were associated with rs244715, rs1046089, rs4806660, and rs2303369. The rs16991615 was also associated with RBC count, and rs451417 was associated with NEUTs. The decision tree (DT) model reveals that women with the NEUT count at a cut-off value of less than 2.8 and HCT equal to or more than 38.7% could be identified as high-risk cases for POI. Overall, we found the DT approach had a sensitivity = 85%, specificity = 72%, and accuracy = 74%.

Conclusion: The genetic variants involved in POI are associated with changes in reproductive hormone levels and with changes in hematological indices.

背景:卵巢早衰(POI)与不孕症有关。人们对可用于预测 POI 的潜在循环生物标志物知之甚少。我们研究了白细胞、红细胞、血小板指数和 8 个已确定的与 POI 风险相关的单核苷酸多态性(SNPs)之间可能存在的关联:本研究招募了 117 名更年期过早(PM)的妇女和 183 名 40 岁前无更年期史的健康妇女。采用四引物扩增难治性突变系统聚合酶链反应(Tetra ARMS PCR)和等位基因特异性寡核苷酸聚合酶链反应(ASO-PCR)对据报道与 POI 相关的 8 个 SNP 进行基因分型。应用决策树分析检验了血液学参数对确定 POI 风险的诊断价值:结果:患有 POI 的女性中性粒细胞(NEUT)和白细胞(WBC)较低,而红细胞(RBC)、血红蛋白(HGB)、血细胞比容(HCT)、平均血球容积(MCV)和平均细胞血红蛋白(MCH)较高。受影响妇女的血小板(PLT)计数也较低。我们的数据还表明,HGB 和 HCT 计数与 rs16991615 和 rs244715 显著相关。平均血小板体积(MPV)和血小板分布宽度(PDW)与 rs244715、rs1046089、rs4806660 和 rs2303369 相关。rs16991615 还与红细胞计数相关,而 rs451417 则与 NEUTs 相关。决策树(DT)模型显示,NEUT 数量的临界值小于 2.8 且 HCT 等于或大于 38.7% 的妇女可被确定为 POI 的高风险病例。总体而言,我们发现 DT 方法的灵敏度为 85%,特异度为 72%,准确度为 74%:结论:POI 所涉及的基因变异与生殖激素水平的变化和血液指标的变化有关。
{"title":"Hematological Indices and Genetic Variants of Premature Ovarian Insufficiency: Machine Learning Approaches.","authors":"Mohammad Reza Mirinezhad, Malihe Aghasizadeh, Hamideh Ghazizadeh, Anahid Hemmatpur, Mohammad Reza Fazl Mashhadi, Hamed Khedmatgozar, Amir Kiyoumarsioskouei, Ali Ebrahimi Dabagh, Mohammad Amin Mohammadi, Arezoo Rastegarmoghadam Ebrahimian, Melika Malek, Sara Moazedi, Simin Rashidian, Gordon A Ferns, Tayebeh Hamzehloei, Alireza Pasdar, Majid Ghayour-Mobarhan","doi":"10.2174/011871529X297081240613075328","DOIUrl":"10.2174/011871529X297081240613075328","url":null,"abstract":"<p><strong>Background: </strong>Premature Ovarian Insufficiency (POI) is associated with infertility. Little is known about the potential circulating biomarkers that could be used to predict POI. We have investigated the possible association between white and red blood cells, platelet indices, and eight established single nucleotide polymorphisms (SNPs) associated with POI risk.</p><p><strong>Methods: </strong>117 women with premature menopause (PM) and 183 healthy women without a history of menopause before age 40 were recruited for this study. The tetra-primer amplification refractory mutation system-polymerase chain reaction (Tetra ARMS PCR) and allele-specific oligonucleotides- polymerase chain reaction (ASO-PCR) were carried out for genotyping for eight SNPs reported to be associated with POI. Decision tree analysis was applied to test the diagnostic value of hematological parameters to identify the risk of POI.</p><p><strong>Results: </strong>Women with POI had lower neutrophil (NEUT) and white blood cell (WBC), whereas red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and mean cell hemoglobin (MCH) were higher. Platelet (PLT) count was also lower in affected women. Our data also indicated that HGB and HCT count were significantly associated with rs16991615 and rs244715. Mean Platelet volume (MPV) and platelet distribution width (PDW) were associated with rs244715, rs1046089, rs4806660, and rs2303369. The rs16991615 was also associated with RBC count, and rs451417 was associated with NEUTs. The decision tree (DT) model reveals that women with the NEUT count at a cut-off value of less than 2.8 and HCT equal to or more than 38.7% could be identified as high-risk cases for POI. Overall, we found the DT approach had a sensitivity = 85%, specificity = 72%, and accuracy = 74%.</p><p><strong>Conclusion: </strong>The genetic variants involved in POI are associated with changes in reproductive hormone levels and with changes in hematological indices.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiovascular & hematological disorders drug targets
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1